AYA in the USA. International Perspectives on AYAO, Part 5
- 1 December 2013
- journal article
- Published by SAGE Publications in Journal of Adolescent and Young Adult Oncology
- Vol. 2 (4) , 167-174
Abstract
Within the past decade, the discipline of adolescent and young adult (AYA) oncology has taken root in the United States. It arose from the observation that survival improvements for 15–39-year-olds have lagged behind those of both children and older adults. Rapid progress in this new area has resulted from energetic work by researchers, clinicians, and non-profit organizations focusing on AYA-aged cancer patients and survivors. The term “AYA” is now well recognized within both pediatric and medical oncology, and AYA-specific aims are increasingly included in clinical trials and also basic and translational oncology research. The AYA oncology movement in the United States was spearheaded by the LIVESTRONG Young Adult Alliance (the Alliance), a coalition of AYA-focused non-profit organizations and academic institutions that has recently transitioned into a successor organization—Critical Mass: The Young Adult Cancer Alliance, composed of individual AYAO professionals. The work of groups such as the Alliance/Critical Mass and key collaborators—including the National Cancer Institute, National Comprehensive Cancer Network, Children's Oncology Group, and advocacy organizations—provides a useful platform for the discussion of progress in AYA oncology in the United States, including advances in (1) research and tool development; (2) public and professional education; (3) advocacy and patient support; (4) awareness; and (5) service delivery. AYA oncology programs are now burgeoning dramatically throughout the United States, and many well-established U.S. programs share distinctive features in clinical programming. The United States is now entering an era of larger-scale coordinated efforts in research, advocacy, and clinical care for AYAs with cancer.Keywords
This publication has 23 references indexed in Scilit:
- Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009JAMA, 2013
- Outcome in adolescent and young adult (AYA) patients compared with younger patients treated for high-risk B-precursor acute lymphoblastic leukemia (HR-ALL): A report from the Children’s Oncology Group study AALL0232.Journal of Clinical Oncology, 2012
- Outcome for adolescent and young adult patients with osteosarcomaCancer, 2012
- Patterns of chemotherapy‐induced toxicities in younger children and adolescents with rhabdomyosarcomaCancer, 2011
- Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy TrialsJournal of Clinical Oncology, 2011
- Treatment outcomes in older adolescent and young adult (AYA) patients with newly diagnosed AML.Journal of Clinical Oncology, 2011
- Unique Characteristics of Adolescent and Young Adult Acute Lymphoblastic Leukemia, Breast Cancer, and Colon CancerJNCI: Journal of the National Cancer Institute, 2011
- Dactinomycin and vincristine toxicity in the treatment of childhood cancer: A retrospective study from the Children's Oncology GroupPediatric Blood & Cancer, 2010
- Quality Cancer Care for Adolescents and Young Adults: A Position StatementJournal of Clinical Oncology, 2010
- Clinical and molecular features of papillary thyroid cancer in adolescents and young adultsCancer, 2010